The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of health-related quality of life during neoadjuvant endocrine therapy with letrozole in postmenopausal breast cancer patients: N-SAS BC06 trial.
Shoichiro Ohtani
No relevant relationships to disclose
Naruto Taira
No relevant relationships to disclose
Kiyohiro Kihara
No relevant relationships to disclose
Yoshie Hasegawa
No relevant relationships to disclose
Takehiko Sakai
No relevant relationships to disclose
Takuji Iwase
No relevant relationships to disclose
Norikazu Masuda
Honoraria - Chugai Pharma
Tomomi Fujisawa
No relevant relationships to disclose
Yasuhiro Yanagita
No relevant relationships to disclose
Shozo Ohsumi
No relevant relationships to disclose
Kenji Higaki
No relevant relationships to disclose
Takuhiro Yamaguchi
No relevant relationships to disclose
Hiroji Iwata
No relevant relationships to disclose